- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Molina Healthcare Inc(MOH)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for MOH
10/23/2026: MOH (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Molina Healthcare is a major managed care provider specializing in government-sponsored programs, primarily serving Medicaid and Medicare-eligible populations. The company is known for its focused operational model and successful history of scaling through strategic state-level acquisitions. Its main growth opportunity lies in increasing penetration in the dual-eligible Medicare market and expanding its Medicaid footprint. However, investors face risks related to regulatory and political shifts, intense competition for state contracts, and reliance on government reimbursement rates. The stock may suit growth-oriented investors looking for exposure to the healthcare sector, though it offers no dividend income and carries volatility related to its specialized business model.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | Molina consistently executes on an acquisition-led growth strategy in the government healthcare sector. |
| Momentum investor | Mixed fit | Momentum depends on positive contract news cycles and consistent quarterly earnings performance. |
| Value investor | Strong fit while signal remains positive | The stock often trades at a valuation that reflects its specialized and somewhat cyclical government-contract business model. |
| Dividend investor | Weak fit | Molina does not pay a dividend, making it unsuitable for income-focused portfolios. |
| Low-risk investor | Mixed fit | Regulatory and political risks inherent to government-sponsored healthcare create moderate volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | The stock is sensitive to policy changes and news regarding state contract renewals. |
| Valuation risk | Medium | Market expectations for growth can cause the stock to trade at a premium, creating potential downside if performance falters. |
| Competition risk (Medicaid and Medicare Managed Care) | High | Intense bidding from larger competitors like UnitedHealth and Centene can threaten contract wins and profitability. |
| Business quality | Medium / high | The company has a focused franchise, but success is highly contingent on administrative and regulatory compliance. |
| Dividend income | Low / none | Investors seeking immediate cash yield will not find it with this stock. |
| Execution risk | Medium | Integrating acquisitions and maintaining operational margins across varying state regulations is inherently challenging. |
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -50.98% | Avg. Invested days 27 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 10.88B USD | Price to earnings Ratio - | 1Y Target Price 219.24 |
Price to earnings Ratio - | 1Y Target Price 219.24 | ||
Volume (30-day avg) 775.7K shares | Beta 0.78 | 52 Weeks Range 121.06 - 244.89 | Updated Date 10/25/2026 |
52 Weeks Range 121.06 - 244.89 | Updated Date 10/25/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.68 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Medicaid Managed Care | State-contracted health plan premiums for low-income beneficiaries. | This is the core engine, generating the bulk of revenue by managing healthcare for low-income populations. |
| Medicare Managed Care | Premiums for Medicare Advantage and D-SNP plans. | A growing revenue stream capturing the increasing number of dual-eligible individuals. |
| Marketplace Insurance | Premium revenue from ACA exchange plans. | Provides revenue exposure to individual insurance markets subsidy-eligible consumers. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2026-10-21 | When After Market | Estimate 0.72 | Actual 0.89 |
Profitability
Profit Margin -0.11% | Operating Margin (TTM) 1% |
Management Effectiveness
Return on Assets (TTM) 1.07% | Return on Equity (TTM) -1.15% |
Valuation
Trailing PE - | Forward PE 18.9 | Enterprise Value 5.02B | Price to Sales(TTM) 0.26 |
Enterprise Value 5.02B | Price to Sales(TTM) 0.26 | ||
Enterprise Value to Revenue 0.11 | Enterprise Value to EBITDA 13.53 | Shares Outstanding 52.00M | Shares Floating 47.88M |
Shares Outstanding 52.00M | Shares Floating 47.88M | ||
Percent Insiders 1.42 | Percent Institutions 111.95 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

